{"title":"The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France","authors":"G. de Pouvourville, P. Blin, P. Karam","doi":"10.1007/s10198-019-01123-5","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":22450,"journal":{"name":"The European Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The European Journal of Health Economics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10198-019-01123-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}